Tissue Engineered - Skin Substitutes Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Tissue Engineered - Skin Substitutes Market
Tissue Engineered - Skin Substitutes Market: By Type (Acellular, Cellular Allogeneic, Cellular Autologous, Others); By Application (Burn Injury, Diabetic/Vascular Ulcer and Others); & By Region - Forecast (2018-2023)
Report Code : HCR 0408
Updated Date: 05 June, 2018  
16

Copies sold

    Client Rating

1. Tissue Engineered – Skin Substitute Market Overview
2. Executive Summary
3. Tissue Engineered – Skin Substitute Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis 
      3.2.1. Product Benchmarking
      3.2.2. End User profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Tissue Engineered – Skin Substitute Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Tissue Engineered – Skin Substitute Market– Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Tissue Engineered – Skin Substitute Market- By Type
   6.1. Introduction
   6.2. Acellular
   6.3. Cellular Allogeneic
   6.4. Cellular Autologous
   6.5. Others
7. Tissue Engineered – Skin Substitute Market- By Application
   7.1. Introduction
   7.2. Burn Injury
      7.2.1. Heat
      7.2.2. Electricity
      7.2.3. Radiation
   7.3. Diabetic/Vascular Ulcer
   7.4. Others
8. Tissue Engineered – Skin Substitute Market- By Geography
   8.1. North America 
      8.1.1. U.S.  
      8.1.2. Canada 
      8.1.3. Mexico 
      8.1.4. Rest of North America
   8.2. South America 
      8.2.1. Brazil 
      8.2.2. Venezuela
      8.2.3. Argentina
      8.2.4. Ecuador
      8.2.5. Peru
      8.2.6. Colombia 
      8.2.7. Costa Rica
      8.2.8. Rest of South America
   8.3. Europe 
      8.3.1. U.K 
      8.3.2. Germany 
      8.3.3. Italy 
      8.3.4. France
      8.3.5. Netherlands
      8.3.6. Belgium
      8.3.7. Spain
      8.3.8. Denmark
      8.3.9. Rest of Europe
   8.4. APAC
      8.4.1. China 
      8.4.2. Australia 
      8.4.3. South Korea
      8.4.4. India
      8.4.5. Taiwan
      8.4.6. Malaysia
      8.4.7. Hong Kong  
      8.4.8. Rest of APAC
   8.5. Middle East& Africa 
      8.5.1. Israel
      8.5.2. South Africa
      8.5.3. Saudi Arabia
   8.6. Rest of Middle East and Africa
9. Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, JVs, Partnership
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   10.1. 3M Inc (U.S.)
   10.2. Acelity L.P. Inc (U.S.)
   10.3. BSN Medical GmbH (Germany)
   10.4.Convatec Group Plc (U.K.)
   10.5. Integra LifeSciences Holdings Corporation (U.S.)
   10.6. Molnlycke Healthcare AB (Sweden)
   10.7. Organogenesis Inc. (U.S.)
   10.8. Shire Plc (U.S.)
   10.9. Smith & Nephew PLC (U.K.)
   10.10. Medtronic (Ireland)
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll